HHS Earnings Prediction
The chart below shows how HHS performed 10 days before and after its earnings report, based on data from the past quarters. Typically, HHS sees a -1.11% change in stock price 10 days leading up to the earnings, and a -0.76% change 10 days following the report. On the earnings day itself, the stock moves by -0.03%. This data can give you a slight idea of what to expect for the next quarter's release.
HHS Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
47.63M
1.08%
5.76%
Gross Margin
16.78%
0.90%
-1.24%
Operating Margin
5.74%
-7.12%
43.50%
Net Margin
0.30%
-77.10%
-100.49%
EPS
0.02
-75.00%
-100.52%
No Data Available
HHS Earnings Analysis
Harte-Hanks, Inc. Common Stock Corporation (HHS.O) Earnings Conference Call
Positive
Revenue Improvement Q3: In Q3, we reported a 1.1% year-over-year revenue increase, an improvement from the negative 16.6% revenue decline on a comparable basis adjusted for acquired revenue reported in Q3 2023.
Customer Care Revenue Increase: Revenues in the Customer Care segment were $13.1 million in the third quarter of 2024 compared to $11.8 million in the same quarter prior year.
Sales Services Growth: Sales Services increased to $4.2 million compared to $2.2 million in the third quarter of 2023, driven by a large client volume increase.
Operating Income Comparison: The operating income in Q3 2024 was $1.9 million compared to operating income of $2.9 million in Q3 of 2023, with adjusted operating income in the third quarter of 2024 at $3.1 million compared to $3.2 million in Q3 of 2023.
Cash and Cash Equivalents Decline: As of September 30, 2024, we had cash and cash equivalents of $5.9 million, compared to $13.3 million as of September 30, 2023.
Negative
Revenue Improvement Analysis: In Q3, we reported a 1.1% year-over-year revenue increase, an improvement from the negative 16.6% revenue decline on a comparable basis adjusted for acquired revenue that were reported in Q3 2023.
Revenue Turnaround Expectations: However, we want to set realistic expectations by acknowledging that our revenue turnaround won't follow a perfectly straight upward path.
Revenue Decline Forecast: In Q4, we expect a low to mid-single digit revenue decline.
Marketing Services Revenue Decline: The marketing services segment revenues fell to $9.1 million in the third quarter of 2024 compared to $10.6 million in the prior year.
Operating Expenses Comparison: Operating expenses in Q3 were $45.7 million, including restructuring expenses of $836,000, compared to $44.2 million in the same period of 2023.
HHS FAQs
How does HHS typically perform around its earnings report dates?
Is Harte Hanks, Inc. (HHS) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
HHS Earning Call Sentiment
Harte Hanks, Inc. (HHS) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
HHS.O
-2.05%Positive
The earnings call presents mixed results. The slight revenue increase and strategic initiatives like Project Elevate and sales team expansion show potential. However, the anticipated revenue decline in Q4, increased operating expenses, decreased operating income, and lack of shareholder returns weigh negatively. The negative sentiment is compounded by substantial cash outflow due to pension plan termination and economic pressures affecting revenue growth. The Q&A session did not provide additional insights to alter this view. Overall, the company's financial health and guidance suggest a negative stock price reaction.
